Bringing the fundamentals into focus…
Back to ADMA Biologics, Inc.
How ADMA Biologics, Inc. stacks up
ADMA · against 335 other Healthcare companies of similar size
Growth
67/ 100
Above the middle of the pack.
Ranked #117 of 336 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score41 peers with a growth score of 60–69, including ADMA · Click a bar to see the companies
Why growth scores 67?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- slower growth in earnings per share: weaker than 80% of peers. Earnings per share growth: -25.9% vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 8.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 89% of peers. 3-year revenue growth: 35.0% vs peer median 5.8%
Metric by metric
Position: dot = ADMA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ADMA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 335 reported | 8.0% | 6.7% | 53% | 33% | |
| Earnings per share growthHigher is better · 196 reported | -25.9% | 9.8% | 15% | 33% | |
| 3-year revenue growthHigher is better · 327 reported | 35.0% | 7.6% | 88% | 33% |
Ranking by growth score
Top 5 and the companies ranked around ADMA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 113 | 22.0B SEK (≈$2.2B) | 71 | 51 | |
| 114 | 4.0B USD | 69 | 56 | |
| 115 | 32.6B HKD (≈$4.2B) | 68 | 60 | |
| 115 | 2.6B USD | 68 | 66 | |
| 117 | 2.5B USD | 67 | 79 | |
| 117 | 2.4B USD | 67 | 64 | |
| 117 | 21.5B DKK (≈$3.2B) | 67 | 58 | |
| 117 | 15.7B SEK (≈$1.6B) | 67 | 51 | |
| 117 | 2.2B USD | 67 | 66 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score